Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXC XR Open-Label Extension in Refractory Partial Epilepsy
NCT00908349Phase 3Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Jun 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of oxcarbazepine in partial epilepsy, sponsored by Supernus Pharmaceuticals, Inc.. Started Jun 2009; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00908349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908349.